Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC)
Titel:
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC)
Auteur:
Garon, Edward B. Cho, Byoung Chul Reinmuth, Niels Lee, Ki Hyeong Luft, Alexander Ahn, Myung-Ju Robinet, Gilles Le Moulec, Sylvestre Natale, Ronald Schneider, Jeffrey Shepherd, Frances A. Garassino, Marina Chiara Geater, Sarayut Lucien Szekely, Zsolt Papai Van Ngoc, Tran Liu, Feng Scheuring, Urban Patel, Nikunj Peters, Solange Rizvi, Naiyer A.